Erganeo is a SATT (Societe d'Acceleration du Transfert de Technologies) founded January 26 2012 in Paris (SIREN 539868224 SAS HQ 30 rue de Gramont 75002 Paris), funded by the French State through the Programme d'Investissements d'Avenir…Read full bio
1 fund tracked, 32 portfolio companies (30 active · 2 realized). Verified weekly from public filings and deal announcements.
Erganeo is a venture capital platform based in Paris with capital deployed across 2 active fund vehicles and a founding year of 2012. The firm targets European and selectively global technology companies across healthcare, software, TMT and energy, with capital deployed across early-stage and Series A/B rounds alongside institutional limited partners.
The platform deploys venture capital into healthcare, software, TMT and energy categories with a focus on technology-enabled businesses across France and selectively across Europe. Investment focus spans seed and growth stages with capital deployed across multiple rounds per portfolio company, supporting founder teams through international scaling and selective M&A activity. The fund structure enables longer holding periods than typical venture vehicles, supporting category-leadership outcomes in technology platforms with global ambitions.
Recent realised exits include Carboneo (energy, 2024), Methys Dx (healthcare, 2023), Argument Theory (diversified sectors, 2022) and HephIA (software, 2022). The platform tracks 2 fund vehicles, 22 active portfolio companies and 6 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in